Revance Therapeutics, Inc. - COM (RVNC)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM
Number of holders
189
Total Shares
73.8M
Shares change
+5.93M
Total reported value, excl. options
$1.36B
Value change
+$97.4M
Put/Call ratio
0.35
Number of buys
109
Number of sells
-73
Price
$18.46
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.